Drug General Information
Drug ID
D06VFO
Former ID
DNAP001613
Drug Name
Anisodamine
Drug Type
Small molecular drug
Indication Central and peripheral nervous diseases [ICD10:G96.9] Approved [551871]
Structure
Download
2D MOL

3D MOL

Formula
C17H23NO4
Canonical SMILES
CN1C2CC(CC1C(C2)O)OC(=O)C(CO)C3=CC=CC=C3
InChI
1S/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-11/h2-6,12-16,19-20H,7-10H2,1H3/t12-,13+,14-,15+,16+/m1/s1
InChIKey
WTQYWNWRJNXDEG-LEOABGAYSA-N
CAS Number
CAS 55869-99-3
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Beta-1 adrenergic receptor Target Info Modulator [533488]
KEGG Pathway Calcium signaling pathway
cGMP-PKG signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Endocytosis
Adrenergic signaling in cardiomyocytes
Gap junction
Salivary secretion
Dilated cardiomyopathy
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Beta1 adrenergic receptor signaling pathway
PathWhiz Pathway Muscle/Heart Contraction
Reactome Adrenoceptors
G alpha (s) signalling events
WikiPathways Monoamine GPCRs
Calcium Regulation in the Cardiac Cell
GPCRs, Class A Rhodopsin-like
Endothelin Pathways
GPCR ligand binding
GPCR downstream signaling
References
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 533488Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965-81.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.